Transcode Therapeutics, Inc. SEC filings RNAZ
Transcode Therapeutics, Inc. has 324 filings in SEC EDGAR's recent list, going back to Dec 18, 2020. Its latest annual report, Form ARS, was filed on Jun 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 3 | Initial insider ownership | Sep 21, 2026 | Sep 10, 2026 |
| 4 | Insider transaction | Sep 11, 2026 | Sep 9, 2026 |
| 4 | Insider transaction | Aug 5, 2026 | Aug 3, 2026 |
| 3 | Initial insider ownership | Aug 5, 2026 | Jul 27, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 3, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 28, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 28, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 28, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 27, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 23, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 20, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 7, 2026 | — |
| 3 | Initial insider ownership | Dec 22, 2025 | Oct 6, 2025 |
| 3 | Initial insider ownership | Dec 22, 2025 | Dec 19, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 10, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 28, 2025 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Oct 16, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Mar 20, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 3, 2025 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 6, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Jul 26, 2024 | — |
| SC 13D | Ownership over 5% (active) | Jun 21, 2024 | — |
| 4 | Insider transaction | Jun 18, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 14, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 15, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Dec 7, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Oct 10, 2023 | — |
| 4 | Insider transaction | Oct 2, 2023 | Sep 28, 2023 |
| 4 | Insider transaction | Oct 2, 2023 | Sep 28, 2023 |
| SC 13G | Ownership over 5% (passive) | Sep 26, 2023 | — |
| 4 | Insider transaction | Jun 22, 2023 | Jun 20, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Jun 16, 2023 | — |
| 4/A | Ownership document | Jun 14, 2023 | Jun 9, 2023 |
| 4 | Insider transaction | Jun 13, 2023 | Jun 9, 2023 |
| 4 | Insider transaction | May 19, 2023 | May 19, 2023 |
| 4 | Insider transaction | May 19, 2023 | May 19, 2023 |
| 4 | Insider transaction | May 19, 2023 | May 19, 2023 |
| 4 | Insider transaction | May 19, 2023 | May 19, 2023 |
| 4 | Insider transaction | May 19, 2023 | May 19, 2023 |
| 4 | Insider transaction | May 10, 2023 | May 10, 2023 |
| 4 | Insider transaction | May 10, 2023 | May 10, 2023 |
| 4 | Insider transaction | May 10, 2023 | May 10, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 10, 2023 | — |
| SC 13D | Ownership over 5% (active) | Dec 20, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Dec 20, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Dec 20, 2022 | — |
| 4 | Insider transaction | Dec 14, 2022 | Dec 12, 2022 |
| 4 | Insider transaction | Dec 14, 2022 | Dec 12, 2022 |
| 4 | Insider transaction | Dec 14, 2022 | Dec 12, 2022 |
| 4 | Insider transaction | Dec 14, 2022 | Feb 1, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 27, 2022 | — |
| 4 | Insider transaction | Sep 16, 2022 | Sep 14, 2022 |
| 4 | Insider transaction | Jun 22, 2022 | Jun 22, 2022 |
| 4 | Insider transaction | Jun 22, 2022 | Jun 22, 2022 |
| 4 | Insider transaction | Jun 22, 2022 | Jun 22, 2022 |
| 4 | Insider transaction | Jun 17, 2022 | Jun 16, 2022 |
| 4 | Insider transaction | Jun 1, 2022 | May 27, 2022 |
| 4 | Insider transaction | Mar 2, 2022 | Mar 1, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 11, 2022 | — |
| 4 | Insider transaction | Feb 3, 2022 | Feb 1, 2022 |
| 4 | Insider transaction | Feb 3, 2022 | Feb 1, 2022 |
| SC 13G | Ownership over 5% (passive) | Jul 21, 2021 | — |
| 3 | Initial insider ownership | Jul 8, 2021 | Jul 8, 2021 |
| 3 | Initial insider ownership | Jul 8, 2021 | Jul 8, 2021 |
| 3 | Initial insider ownership | Jul 8, 2021 | Jul 8, 2021 |
| 3 | Initial insider ownership | Jul 8, 2021 | Jul 8, 2021 |
| 3 | Initial insider ownership | Jul 8, 2021 | Jul 8, 2021 |
| 3 | Initial insider ownership | Jul 8, 2021 | Jul 8, 2021 |
| 3 | Initial insider ownership | Jul 8, 2021 | Jul 8, 2021 |
Showing 77 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RNAZ (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1829635
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.